Development and evaluation of clinical models based on ultrasound, serum CA153 and molecular subtype in predicting the efficacy of neoadjuvant chemotherapy in breast cancer

Ming-Yue Du, Shu-E Zeng

Open source

DOI
10.3892/ol.2026.15841
Published
2026-09-02
Container
Oncology Letters
Publisher
Spandidos Publications
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3892/ol.2026.15841,
  title = {Development and evaluation of clinical models based on ultrasound, serum CA153 and molecular subtype in predicting the efficacy of neoadjuvant chemotherapy in breast cancer},
  author = {Ming-Yue Du and Shu-E Zeng},
  year = {2026},
  journal = {Oncology Letters},
  doi = {10.3892/ol.2026.15841},
  url = {https://doi.org/10.3892/ol.2026.15841}
}

RIS

TY  - JOUR
TI  - Development and evaluation of clinical models based on ultrasound, serum CA153 and molecular subtype in predicting the efficacy of neoadjuvant chemotherapy in breast cancer
AU  - Ming-Yue Du
AU  - Shu-E Zeng
PY  - 2026
JO  - Oncology Letters
DO  - 10.3892/ol.2026.15841
UR  - https://doi.org/10.3892/ol.2026.15841
ER  - 

APA

Du, M., & Zeng, S. (2026). Development and evaluation of clinical models based on ultrasound, serum CA153 and molecular subtype in predicting the efficacy of neoadjuvant chemotherapy in breast cancer. Oncology Letters. https://doi.org/10.3892/ol.2026.15841

Source records